Published Date：Jan. 2021
Industry：Pharma & Healthcare
Pages：112 Table Number：137
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Virus Like Particles market in this environment. In terms of revenue, this research report indicated that the global Virus Like Particles market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Virus Like Particles industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The GlaxoSmithKline aims at producing XX Virus Like Particles in 2020, with XX % production to take place in global market, Merck accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Virus Like Particles Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Virus Like Particles Market? GlaxoSmithKline Merck Novavax Takeda Medicago MedImmune TechnoVax Agilvax Allergy Therapeutics Serum Institute of India GeoVax Labs Cytos Biotechnology ANGANY Genetics CPL Biologicals Xiamen Innovax Biotech ... Major Type of Virus Like Particles Covered in XYZResearch report: Adeno-Associated Virus HIV Hepatitis B Virus Hepatitis C Virus Other Application Segments Covered in XYZResearch Market Vaccines Mycoviruses Virus Research Therapeutic and Imaging Agents Other For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Virus Like Particles Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Adeno-Associated Virus -Product Introduction and Major Manufacturers 1.1.2 HIV -Product Introduction and Major Manufacturers 1.1.3 Hepatitis B Virus -Product Introduction and Major Manufacturers 1.1.4 Hepatitis C Virus -Product Introduction and Major Manufacturers 1.1.5 Other -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Virus Like Particles Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Virus Like Particles Market 3.1.1 Top Companies leading Virus Like Particles Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Virus Like Particles Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Virus Like Particles Market 3.2.1 Top Companies leading Virus Like Particles Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Virus Like Particles Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Virus Like Particles Market 3.3.1 Top Companies leading Virus Like Particles Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Virus Like Particles Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Virus Like Particles Market 3.4.1 Top Companies leading Virus Like Particles Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Virus Like Particles Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Virus Like Particles Market 3.5.1 Top Companies leading Virus Like Particles Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Virus Like Particles Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Virus Like Particles Market 3.6.1 Top Companies leading Virus Like Particles Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Virus Like Particles Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Virus Like Particles Market 3.7.1 Top Companies leading Virus Like Particles Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Virus Like Particles Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Virus Like Particles Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Virus Like Particles Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Virus Like Particles Sales and Growth Rate (2021-2026) 5.2 Global Virus Like Particles Sales Value and Growth Rate (2021-2026) 6 Virus Like Particles Competitive Analysis 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline Company Profiles 6.1.2 GlaxoSmithKline Product Introduction 6.1.3 GlaxoSmithKline Virus Like Particles Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Merck 6.2.1 Merck Company Profiles 6.2.2 Merck Product Introduction 6.2.3 Merck Virus Like Particles Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Novavax 6.3.1 Novavax Company Profiles 6.3.2 Novavax Product Introduction 6.3.3 Novavax Virus Like Particles Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Takeda 6.4.1 Takeda Company Profiles 6.4.2 Takeda Product Introduction 6.4.3 Takeda Virus Like Particles Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Medicago 6.5.1 Medicago Company Profiles 6.5.2 Medicago Product Introduction 6.5.3 Medicago Virus Like Particles Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 MedImmune 6.6.1 MedImmune Company Profiles 6.6.2 MedImmune Product Introduction 6.6.3 MedImmune Virus Like Particles Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 TechnoVax 6.7.1 TechnoVax Company Profiles 6.7.2 TechnoVax Product Introduction 6.7.3 TechnoVax Virus Like Particles Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Agilvax 6.8.1 Agilvax Company Profiles 6.8.2 Agilvax Product Introduction 6.8.3 Agilvax Virus Like Particles Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Allergy Therapeutics 6.9.1 Allergy Therapeutics Company Profiles 6.9.2 Allergy Therapeutics Product Introduction 6.9.3 Allergy Therapeutics Virus Like Particles Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Serum Institute of India 6.10.1 Serum Institute of India Company Profiles 6.10.2 Serum Institute of India Product Introduction 6.10.3 Serum Institute of India Virus Like Particles Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 GeoVax Labs 6.12 Cytos Biotechnology 6.13 ANGANY Genetics 6.14 CPL Biologicals 6.15 Xiamen Innovax Biotech 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Virus Like Particles Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Virus Like Particles Sales (K Unit) by Type (2015-2026) Figure Global Virus Like Particles Sales (K Unit) and Growth Rate (2015-2026) Figure Global Virus Like Particles Sales Market Share (%) by Type (2019 -2020) Table Global Virus Like Particles Sales Value (Million USD) by Type (2015-2026) Figure Global Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Virus Like Particles Sales Value Market Share (%) by Type (2019-2020) Table Global Virus Like Particles Sales (K Unit) by Application (2015-2026) Table China Virus Like Particles Sales (K Unit) of Major Company (2015-2020) Table China Virus Like Particles Sales Market Share of Major Company (2015-2020) Table China Virus Like Particles Sales Value (Million USD) of Major Company (2015-2020) Figure China Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2020) Table China Virus Like Particles Sales Value Share of Major Company (2015-2020) Table China Virus Like Particles Price (USD/Unit), by Type (2019-2020) Table China Virus Like Particles Sales (Unit) by Type (2015-2026) Figure China Virus Like Particles Sales (Unit) by Type (2015-2026) Table EU Virus Like Particles Sales (K Unit) of Major Company (2015-2020) Table EU Virus Like Particles Sales Market Share of Major Company (2015-2020) Table EU Virus Like Particles Sales Value (Million USD) of Major Company (2015-2020) Figure EU Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Virus Like Particles Sales Value Share of Major Company (2015-2020) Table EU Virus Like Particles Price (USD/Unit), by Type (2019-2020) Table EU Virus Like Particles Sales (Unit) by Type (2015-2026) Figure EU Virus Like Particles Sales (Unit) by Type (2015-2026) Table USA Virus Like Particles Sales (K Unit) of Major Company (2015-2020) Table USA Virus Like Particles Sales Market Share of Major Company (2015-2020) Table USA Virus Like Particles Sales Value (Million USD) of Major Company (2015-2020) Figure USA Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Virus Like Particles Sales Value Share of Major Company (2015-2020) Table USA Virus Like Particles Price (USD/Unit), by Type (2019-2020) Table USA Virus Like Particles Sales (Unit) by Type (2015-2026) Figure USA Virus Like Particles Sales (Unit) by Type (2015-2026) Table Japan Virus Like Particles Sales (K Unit) of Major Company (2015-2020) Table Japan Virus Like Particles Sales Market Share of Major Company (2015-2020) Table Japan Virus Like Particles Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Virus Like Particles Sales Value Share of Major Company (2015-2020) Table Japan Virus Like Particles Price (USD/Unit), by Type (2019-2020) Table Japan Virus Like Particles Sales (Unit) by Type (2015-2026) Figure Japan Virus Like Particles Sales (Unit) by Type (2015-2026) Table India Virus Like Particles Sales (K Unit) of Major Company (2015-2020) Table India Virus Like Particles Sales Market Share of Major Company (2015-2020) Table India Virus Like Particles Sales Value (Million USD) of Major Company (2015-2020) Figure India Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2020) Table India Virus Like Particles Sales Value Share of Major Company (2015-2020) Table India Virus Like Particles Price (USD/Unit), by Type (2019-2020) Table India Virus Like Particles Sales (Unit) by Type (2015-2026) Figure India Virus Like Particles Sales (Unit) by Type (2015-2026) Table Southeast Asia Virus Like Particles Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Virus Like Particles Sales Market Share of Major Company (2015-2020) Table Southeast Asia Virus Like Particles Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Virus Like Particles Sales Value Share of Major Company (2015-2020) Table Southeast Asia Virus Like Particles Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Virus Like Particles Sales (Unit) by Type (2015-2026) Figure Southeast Asia Virus Like Particles Sales (Unit) by Type (2015-2026) Table South America Virus Like Particles Sales (K Unit) of Major Company (2015-2020) Table South America Virus Like Particles Sales Market Share of Major Company (2015-2020) Table South America Virus Like Particles Sales Value (Million USD) of Major Company (2015-2020) Figure South America Virus Like Particles Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Virus Like Particles Sales Value Share of Major Company (2015-2020) Table South America Virus Like Particles Price (USD/Unit), by Type (2019-2020) Table South America Virus Like Particles Sales (Unit) by Type (2015-2026) Figure South America Virus Like Particles Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Virus Like Particles Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Virus Like Particles Figure Cost Structure of Virus Like Particles in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Virus Like Particles Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Virus Like Particles Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table GlaxoSmithKline Profiles Table GlaxoSmithKline Virus Like Particles Product Introduction Table GlaxoSmithKline Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure GlaxoSmithKline SWOT Analysis Table Merck Profiles Table Merck Virus Like Particles Product Introduction Table Merck Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Merck SWOT Analysis Table Novavax Profiles Table Novavax Virus Like Particles Product Introduction Table Novavax Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Novavax SWOT Analysis Table Takeda Profiles Table Takeda Virus Like Particles Product Introduction Table Takeda Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Takeda SWOT Analysis Table Medicago Profiles Table Medicago Virus Like Particles Product Introduction Table Medicago Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Medicago SWOT Analysis Table MedImmune Profiles Table MedImmune Virus Like Particles Product Introduction Table MedImmune Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure MedImmune SWOT Analysis Table TechnoVax Profiles Table TechnoVax Virus Like Particles Product Introduction Table TechnoVax Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure TechnoVax SWOT Analysis Table Agilvax Profiles Table Agilvax Virus Like Particles Product Introduction Table Agilvax Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Agilvax SWOT Analysis Table Allergy Therapeutics Profiles Table Allergy Therapeutics Virus Like Particles Product Introduction Table Allergy Therapeutics Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Allergy Therapeutics SWOT Analysis Table Serum Institute of India Profiles Table Serum Institute of India Virus Like Particles Product Introduction Table Serum Institute of India Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Serum Institute of India SWOT Analysis Table GeoVax Labs Profiles Table GeoVax Labs Virus Like Particles Product Introduction Table GeoVax Labs Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure GeoVax Labs SWOT Analysis Table Cytos Biotechnology Profiles Table Cytos Biotechnology Virus Like Particles Product Introduction Table Cytos Biotechnology Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Cytos Biotechnology SWOT Analysis Table ANGANY Genetics Profiles Table ANGANY Genetics Virus Like Particles Product Introduction Table ANGANY Genetics Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ANGANY Genetics SWOT Analysis Table CPL Biologicals Profiles Table CPL Biologicals Virus Like Particles Product Introduction Table CPL Biologicals Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure CPL Biologicals SWOT Analysis Table Xiamen Innovax Biotech Profiles Table Xiamen Innovax Biotech Virus Like Particles Product Introduction Table Xiamen Innovax Biotech Virus Like Particles Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
